Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice

Journal of the American Geriatrics Society

Volumn 45, Issue 7, 1997, Pages 809-812

  Fishkind, Deborah ^b   Paris, Barbara E C ^b   Aronow, Wilbert S ^a,b  

^a American Geriatrics Society   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ISRADIPINE; NIFEDIPINE; VERAPAMIL;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG CHOICE; DRUG INDICATION; DRUG UTILIZATION; FEMALE; GERIATRIC CARE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE;

EID: 0030859260     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb01506.x     Document Type: Article

References (34)

1. Aronow WS. Optimal management of older patients with atrial fibrillation. Drugs Aging 1994;4:184-193.
2. Aronow WS. Digoxin or angiotensin converting enzyme inhibitors for congestive heart failure in geriatric patients. Which is the preferred treatment? Drugs Aging 1991;1:98-103.
3. Aronow WS. Prevalence of appropriate and inappropriate indications for use of digoxin in older patients at the time of admission to a nursing home. J Am Geriatr Soc 1996;44:588-590.
4. Hawkins CM, Richardson DW, Vokonas PS. Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience. Circulation 1983;67(suppl I):I-94-97.
5. Gundersen T, Abrahamsen AM, Kjekshus J et al. Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction. Circulation 1982;66:1179-1184.
6. Hjalmarson A, Herlitz J, Holmberg S et al. The Goteborg Metoprolol Trial: Effects on mortality and morbidity in acute myocardial infarction. Circulation 1983;67(suppl I):I-26-31.
7. Aronow WS, Ahn C, Mercando AD et al. Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients ≥ 62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction ≥ 40%. Am T Cardiol 1994;74:267-270.
8. Park KC, Forman DE, Wei JY. Utility of beta-blockade treatment for older postinfarction patients. J Am Geriatr Soc 1995;43:751-755.
9. 1993 Joint National Committee. The Fifth Report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
10. Aronow WS. Prevalence of use of beta blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home. J Am Geriatr Soc 1996;44:1075-1077.
11. Murgatroyd FD, Xie B, Gibson SM et al. The effects of digoxin in patients with paroxysmal atrial fibrillation: Analysis of Holter data from the CRAFT-1 Trial. J Am Coll Cardiol (Abstract) 1993;21:203A.
12. Rawles JM, Metcalfe MJ, Jennings K. Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: The effect of digoxin. Br Heart J 1990:63:225-227.
13. Galun E, Flugelman MY, Glickson M, Eliakim M. Failure of long-term digitalization to prevent rapid ventricular response in patients with paroxysmal atrial fibrillation. Chest 1991;99:1038-1040.
14. Kennedy HL, Brooks MM, Barker AH et al. Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trial. Am J Cardiol 1994;74:674-680.
15. Chadda K, Goldstein S, Byington R et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 1986;73:503-510.
16. The Beta-Blocker Pooling Project Research Group. The Beta-Blocker Pooling Project (BBPP): Subgroup findings from randomised trials in post-infarction patients. Eur Heart J 1988;9:8-16.
17. Forman DE, Wei JY. Beta-blockade in older patients with myocardial infarction (Letter to the Editor). JAMA 1991;266:2222.
18. Gurwitz JH, Goldberg RJ, Chen Z et al. Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med 1992;93:605-610.
19. Rich MW, Bosner MS, Chung MK et al. Is age an independent predictor of early and late mortality in patients with acute myocardial infarction. Am J Med 1992:92:7-13.
20. Montague TJ, Ikuta RM, Wong RY et al. Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two year period (1987-1989). Am J Cardiol 1991;68:843-847.
21. Zuanetti G, Latini R Avanzini F, et al. Use of beta-blocking agents after myocardial infarction. The GISSI experience. Circulation (Abstract)1995;92(suppl I):I-196.
22. Held PH, Yusuf S. Impact of calcium channel blockers on mortality in survivors of acute myocardial infarction. In: Singh BN, Wellens HJJ, Hiraoka M, eds. Electropharmacological Control of Cardiac Arrhythmias. Mount Kisco, NY: Futura Publishing Co, Inc; 1994:399-411.
23. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
24. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:385-392.
25. Goldstein RE, Boccuzzi SJ, Cruess D et al. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 1991;83:52-60.
26. Elkayam U, Amin J, Mehra A et al. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 1990;82:1954-1961.
27. Danish Study Group on Verapamil in Myocardial Infarction Trial II-DAVIT II. Effect of verapamil on mortality and major events after acute myocardial infarction. Am J Cardiol 1990;66:779-785.
28. Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450-1456.
29. Pfeffer MA, Braunwald E, Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-677.
30. Psaty BM, Heckbert SR, Koepsell TD et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.
31. Pahor M, Guralnik JM, Corti M-C et al. Long-term survival and use of anti-hypertensive medications in older persons. J Am Geriatr Soc 1995;43:1191-1197.
32. Borhani NO, Mercuri M, Borhani PA et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA 1996;276:785-791.
33. Ferguson JJ, Momomura S. Highlights from the 58th annual scientific meeting of the Japanese Circulation Society. Circulation 1994;90:2194-2196.
34. Pahor M, Guralnik JM, Ferrucci L et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996;348:493-497.